Keyphrases
Quercetin
53%
Carrageenan
40%
Non-alcoholic Fatty Liver Disease (NAFLD)
35%
Polymer Concentration
35%
High-fat Diet
35%
Fluvoxamine
31%
Osteoarthritis
30%
Morphine
29%
MRNA Expression
28%
Lung
27%
Knee Osteoarthritis
26%
Selective Serotonin Reuptake Inhibitors
22%
Sleep Disturbance
22%
Alginate
22%
Stress-induced Gastric Ulcer
20%
Constipation
19%
Nicotine
19%
Moisture Content
18%
Rewarding Effect
18%
Neuropathic Pain
17%
Inhalable Microspheres
17%
Danio Rerio
17%
Zebrafish Embryo
17%
5-HT1A Receptor
17%
Liver Disease Models
17%
Drug-related Problems
17%
Dry Powder Inhaler
17%
Aquaporin-3 (AQP3)
17%
Aqueous Extract
17%
House Dust Mite
17%
Diet-induced
17%
Emergency Department
17%
Indonesian
17%
Potentially Inappropriate Medication
17%
Epigallocatechin Gallate
17%
Medication Complexity
17%
Erythropoietin
17%
Resveratrol
17%
Andrographolide
17%
Behavior Change
17%
Solid Lipid Microparticles
17%
Methamphetamine
17%
Aerosolization
16%
Depressive-like Behavior
16%
Sigma-1 Receptor
16%
Inhalable
16%
Liver
16%
Opioids
15%
Pulmonary Delivery
15%
κ-carrageenan
15%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Microsphere
65%
Quercetin
53%
Carrageenan
44%
Fluvoxamine
33%
Opiate
29%
Alginic Acid
29%
Nonalcoholic Fatty Liver
26%
Microparticle
26%
Morphine
26%
Disease
26%
Selective Serotonin Reuptake Inhibitor
25%
Sleep Disorder
23%
Stomach Ulcer
23%
Ciprofloxacin
20%
Constipation
19%
Neuropathic Pain
19%
Malignant Neoplasm
19%
Dry Powder Inhaler
17%
Erythropoietin
17%
Andrographolide
17%
Zebra Fish
17%
Resveratrol
17%
Orexin
17%
Acute Toxicity
17%
Polypharmacy
14%
Brain Ischemia
14%
Observational Study
13%
Cigarette Smoke
13%
Surfactant
13%
Adverse Drug Reaction
12%
Prevalence
11%
Inflammation
11%
Desensitization
10%
Side Effect
10%
Knockout Mouse
10%
Neuroprotective Agent
10%
Non Insulin Dependent Diabetes Mellitus
10%
Carotid Artery Obstruction
10%
Aquaporin 3
9%
Opiate Receptor
9%
Respiratory Tract Disease
9%
Tobacco Dependence
9%
Drug Delivery System
9%
Knee Osteoarthritis
8%
Anticonvulsive Agent
8%
Drug Formulation
8%
Janus Kinase 1
8%
Olanzapine
8%
Janus Kinase 3 Inhibitor
8%